Characterization of Induced Pluripotent Stem Cell Microvesicle Genesis, Morphology and Pluripotent Content

Scientific Reports
Jing ZhouStephen Redenti

Abstract

Microvesicles (MVs) are lipid bilayer-covered cell fragments that range in diameter from 30 nm-1 uM and are released from all cell types. An increasing number of studies reveal that MVs contain microRNA, mRNA and protein that can be detected in the extracellular space. In this study, we characterized induced pluripotent stem cell (iPSC) MV genesis, content and fusion to retinal progenitor cells (RPCs) in vitro. Nanoparticle tracking revealed that iPSCs released approximately 2200 MVs cell/hour in the first 12 hrs with an average diameter of 122 nm. Electron and light microscopic analysis of iPSCs showed MV release via lipid bilayer budding. The mRNA content of iPSC MVs was characterized and revealed the presence of the transcription factors Oct-3/4, Nanog, Klf4, and C-Myc. The protein content of iPSCs MVs, detected by immunogold electron microscopy, revealed the presence of the Oct-3/4 and Nanog. Isolated iPSC MVs were shown to fuse with RPCs in vitro at multiple points along the plasma membrane. These findings demonstrate that the mRNA and protein cargo in iPSC MVs have established roles in maintenance of pluripotency. Building on this work, iPSC derived MVs may be shown to be involved in maintaining cellular pluripotency and ...Continue Reading

References

Aug 3, 2002·Nature Reviews. Immunology·Clotilde ThérySebastian Amigorena
Oct 27, 2004·Investigative Ophthalmology & Visual Science·Henry J KlassenMichael J Young
Mar 15, 2006·The Journal of Cell Biology·Amy M BoothStephen J Gould
Apr 14, 2006·Neoplasia : an International Journal for Oncology Research·P K Y GoonA D Blann
Mar 12, 2008·Traffic·Jeffrey S Schorey, Sanchita Bhatnagar
Apr 1, 2008·Journal of Proteome Research·David M SmalleyDan Theodorescu
Nov 13, 2008·PloS One·Melissa Piper HunterClay B Marsh
Jan 10, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·E PapA Falus
Jan 16, 2009·Trends in Cell Biology·Emanuele CocucciJacopo Meldolesi
Mar 7, 2009·PloS One·Alex YuanDebora B Farber
Apr 25, 2009·Journal of the American Society of Nephrology : JASN·Stefania BrunoGiovanni Camussi
May 12, 2009·Advanced Drug Delivery Reviews·Dirk Grimm
Aug 5, 2009·Journal of Cellular and Molecular Medicine·M B HerreraG Camussi
Mar 5, 2010·Blood Cells, Molecules & Diseases·Anita Mrvar-BreckoVeronika Kralj-Iglic
May 7, 2010·Journal of Cell Science·Vandhana Muralidharan-ChariCrislyn D'Souza-Schorey
Jun 19, 2010·Advanced Drug Delivery Reviews·Peter J Quesenberry, Jason M Aliotta
Jul 6, 2010·Journal of Proteomics·Suresh MathivananRichard J Simpson
Oct 5, 2010·Critical Reviews in Oncology/hematology·Erna PapAndrás Falus
Oct 19, 2010·Genes & Development·Matthias Stadtfeld, Konrad Hochedlinger
Mar 5, 2011·Biochemical Pharmacology·Michel RecordMarc Poirot
Oct 26, 2011·The International Journal of Biochemistry & Cell Biology·Anna-Kristin Ludwig, Bernd Giebel
Feb 14, 2012·Ocular Immunology and Inflammation·Jingsheng TuoChi-Chao Chan
May 23, 2012·Cell and Tissue Research·Anja Schneider, Mikael Simons
Feb 20, 2013·The Journal of Cell Biology·Graça Raposo, Willem Stoorvogel
Apr 16, 2013·Nature Reviews. Drug Discovery·Samir EL AndaloussiMatthew J A Wood
May 30, 2013·Development·Kazutoshi Takahashi, Shinya Yamanaka
Apr 9, 2014·Cell Research·Basant Kumar ThakurDavid Lyden
Jun 22, 2014·The Journal of Biological Chemistry·Tian TianZhong-Dang Xiao
Sep 28, 2014·The Journal of Biological Chemistry·Yaxuan LiangLara K Mahal

❮ Previous
Next ❯

Citations

May 20, 2016·Stem Cells International·Alejandro LuarteCarlos Lafourcade
Dec 19, 2019·Tissue Engineering. Part B, Reviews·Richard JeskeYan Li
Feb 23, 2020·Investigative Ophthalmology & Visual Science·Jason MightyStephen Redenti
Apr 26, 2020·Journal of Cardiovascular Translational Research·Nana HeHonghua Ye
Nov 5, 2019·Frontiers in Neuroscience·Yi Xin Fiona LeeSamir El Andaloussi
Aug 6, 2020·International Journal of Molecular Sciences·Daniela Gois BeghiniAndrea Henriques-Pons
Apr 18, 2018·Molecular Neurobiology·Nicole OsierJessica Gill
Oct 27, 2020·Journal of Cardiovascular Pharmacology·Lindsay Kraus, Sadia Mohsin
May 29, 2021·Developmental Biology·Jorge B AquinoLaura A Montaldo

❮ Previous
Next ❯

Methods Mentioned

BETA
scanning electron microscopy
electrophoresis
PCR
flow cytometry
glycosylation

Software Mentioned

Nanoparticle Tracking Analysis ( NTA )
AMT
Nikon Elements

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.